These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

110 related items for PubMed ID: 21339744

  • 1. Metal-free imidazolium salts inhibit the growth of hepatocellular carcinoma in a mouse model.
    Gopalan B, Ke Z, Zhang C, Kng Y, Suhaimi NA, Riduan SN, Zhang Y, Zhuo L.
    Lab Invest; 2011 May; 91(5):744-51. PubMed ID: 21339744
    [Abstract] [Full Text] [Related]

  • 2. Therapeutic effect of a multi-targeted imidazolium compound in hepatocellular carcinoma.
    Gopalan B, Narayanan K, Ke Z, Lu T, Zhang Y, Zhuo L.
    Biomaterials; 2014 Aug; 35(26):7479-87. PubMed ID: 24912819
    [Abstract] [Full Text] [Related]

  • 3. Survivin knockdown by short hairpin RNA abrogates the growth of human hepatocellular carcinoma xenografts in nude mice.
    Zhang R, Ma L, Zheng M, Ren J, Wang T, Meng Y, Zhao J, Jia L, Yao L, Han H, Li K, Yang A.
    Cancer Gene Ther; 2010 Apr; 17(4):275-88. PubMed ID: 19876077
    [Abstract] [Full Text] [Related]

  • 4. Xylocydine, a novel Cdk inhibitor, is an effective inducer of apoptosis in hepatocellular carcinoma cells in vitro and in vivo.
    Cho SJ, Lee SS, Kim YJ, Park BD, Choi JS, Liu L, Ham YM, Moon Kim B, Lee SK.
    Cancer Lett; 2010 Jan 28; 287(2):196-206. PubMed ID: 19616371
    [Abstract] [Full Text] [Related]

  • 5. Effects and mechanisms of silibinin on human hepatocellular carcinoma xenografts in nude mice.
    Cui W, Gu F, Hu KQ.
    World J Gastroenterol; 2009 Apr 28; 15(16):1943-50. PubMed ID: 19399925
    [Abstract] [Full Text] [Related]

  • 6. The over-expression of survivin enhances the chemotherapeutic efficacy of YM155 in human hepatocellular carcinoma.
    Xia H, Chen J, Shi M, Deivasigamani A, Ooi LL, Hui KM.
    Oncotarget; 2015 Mar 20; 6(8):5990-6000. PubMed ID: 25714025
    [Abstract] [Full Text] [Related]

  • 7. Extract Derived from Cedrus atlantica Acts as an Antitumor Agent on Hepatocellular Carcinoma Growth In Vitro and In Vivo.
    Huang XF, Chang KF, Lee SC, Sheu GT, Li CY, Weng JC, Hsiao CY, Tsai NM.
    Molecules; 2020 Oct 10; 25(20):. PubMed ID: 33050385
    [Abstract] [Full Text] [Related]

  • 8. Blockade of Wnt-1 signaling leads to anti-tumor effects in hepatocellular carcinoma cells.
    Wei W, Chua MS, Grepper S, So SK.
    Mol Cancer; 2009 Sep 24; 8():76. PubMed ID: 19778454
    [Abstract] [Full Text] [Related]

  • 9. Nuclear translocation of survivin in hepatocellular carcinoma: a key to cancer cell growth?
    Moon WS, Tarnawski AS.
    Hum Pathol; 2003 Nov 24; 34(11):1119-26. PubMed ID: 14652813
    [Abstract] [Full Text] [Related]

  • 10. N-myc downstream regulated gene1/Cap43 overexpression suppresses tumor growth by hepatic cancer cells through cell cycle arrest at the G0/G1 phase.
    Akiba J, Murakami Y, Noda M, Watari K, Ogasawara S, Yoshida T, Kawahara A, Sanada S, Yasumoto M, Yamaguchi R, Kage M, Kuwano M, Ono M, Yano H.
    Cancer Lett; 2011 Nov 01; 310(1):25-34. PubMed ID: 21775055
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Silencing of signal transducer and activator of transcription 3 expression by RNA interference suppresses growth of human hepatocellular carcinoma in tumor-bearing nude mice.
    Li J, Piao YF, Jiang Z, Chen L, Sun HB.
    World J Gastroenterol; 2009 Jun 07; 15(21):2602-8. PubMed ID: 19496189
    [Abstract] [Full Text] [Related]

  • 14. YC-1 enhances the anti-tumor activity of sorafenib through inhibition of signal transducer and activator of transcription 3 (STAT3) in hepatocellular carcinoma.
    Kong J, Kong F, Gao J, Zhang Q, Dong S, Gu F, Ke S, Pan B, Shen Q, Sun H, Zheng L, Sun W.
    Mol Cancer; 2014 Jan 13; 13():7. PubMed ID: 24418169
    [Abstract] [Full Text] [Related]

  • 15. Survivin promotes cell proliferation in human hepatocellular carcinoma.
    Ito T, Shiraki K, Sugimoto K, Yamanaka T, Fujikawa K, Ito M, Takase K, Moriyama M, Kawano H, Hayashida M, Nakano T, Suzuki A.
    Hepatology; 2000 May 13; 31(5):1080-5. PubMed ID: 10796883
    [Abstract] [Full Text] [Related]

  • 16. Romidepsin induces G2/M phase arrest via Erk/cdc25C/cdc2/cyclinB pathway and apoptosis induction through JNK/c-Jun/caspase3 pathway in hepatocellular carcinoma cells.
    Sun WJ, Huang H, He B, Hu DH, Li PH, Yu YJ, Zhou XH, Lv Z, Zhou L, Hu TY, Yao ZC, Lu MD, Shen X, Zheng ZQ.
    Biochem Pharmacol; 2017 Mar 01; 127():90-100. PubMed ID: 28012958
    [Abstract] [Full Text] [Related]

  • 17. Bevacizumab enhances chemosensitivity of hepatocellular carcinoma to adriamycin related to inhibition of survivin expression.
    Xiong YQ, Sun HC, Zhu XD, Zhang W, Zhuang PY, Zhang JB, Xu HX, Kong LQ, Wu WZ, Qin LX, Tang ZY.
    J Cancer Res Clin Oncol; 2011 Mar 01; 137(3):505-12. PubMed ID: 20490863
    [Abstract] [Full Text] [Related]

  • 18. Survivin inhibitor YM155 suppresses gastric cancer xenograft growth in mice without affecting normal tissues.
    Cheng XJ, Lin JC, Ding YF, Zhu L, Ye J, Tu SP.
    Oncotarget; 2016 Feb 09; 7(6):7096-109. PubMed ID: 26771139
    [Abstract] [Full Text] [Related]

  • 19. Sulfatase 1 (hSulf-1) reverses basic fibroblast growth factor-stimulated signaling and inhibits growth of hepatocellular carcinoma in animal model.
    Xu G, Ji W, Su Y, Xu Y, Yan Y, Shen S, Li X, Sun B, Qian H, Chen L, Fu X, Wu M, Su C.
    Oncotarget; 2014 Jul 15; 5(13):5029-39. PubMed ID: 24970807
    [Abstract] [Full Text] [Related]

  • 20. Small molecule antagonists of Tcf4/beta-catenin complex inhibit the growth of HCC cells in vitro and in vivo.
    Wei W, Chua MS, Grepper S, So S.
    Int J Cancer; 2010 May 15; 126(10):2426-36. PubMed ID: 19662654
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.